Latest / Cyrona Cell Podcast: Stem Cell Therapy in Malaysia / Stem Cell Therapy for Knee Pain: First-Year Expectations
Transcript
- 0:00SPEAKER_00: Welcome to the Cyrona Cell Podcast.
- 0:02SPEAKER_00: So if I told you that uh up to maybe two-thirds of the healing you get from a cutting-edge medical treatment has basically nothing to do with the physical treatment itself, I mean, would you still want the injection?
- 0:15SPEAKER_01: It's a huge question.
- 0:16SPEAKER_00: I think it surprises a lot of people when they actually see the data.
- 0:20SPEAKER_01: It's wild.
- 0:21SPEAKER_00: Because today, our mission for this deep dive is to cut straight through all that vague medical marketing you see online.
- 0:28SPEAKER_00: We want to look at the actual evidence-based data on what you should expect during that first year of stem cell therapy for knee pain.
- 0:34SPEAKER_02: Aaron Powell Exactly.
- 0:35SPEAKER_02: Because you know, we're bringing in a really robust collection of clinical trial data, some major systematic reviews, and medical guidelines today.
- 0:44SPEAKER_02: And these sources track patient progress at very specific checkpoints.
- 0:48SPEAKER_02: So three, six, and twelve months.
- 0:51SPEAKER_00: Aaron Powell Yeah, and that's so important because, well, at Cyrona Cells Clinic in Kuala Lumpur, the doctors constantly see patients flying in from all over the world.
- 0:59SPEAKER_00: I mean, people are coming from Australia, from the Middle East, everywhere.
- 1:02SPEAKER_00: Aaron Powell Right.
- 1:02SPEAKER_02: It's a huge international hub for this.
- 1:04SPEAKER_00: Aaron Powell And almost every single one of them arise asking the exact same question, which is what is physically going to happen to my knee month by month?
- 1:12SPEAKER_00: Setting a realistic recovery timeline for knee pain helps ground those expectations in, you know, actual biological reality instead of just blind optimism.
- 1:21SPEAKER_02: Aaron Powell I couldn't agree more.
- 1:23SPEAKER_02: Getting away from those anecdotal clinic promises and looking at the rigorous science of a full calendar year is crucial.
- 1:30SPEAKER_00: Aaron Powell But I mean, to understand a full year, you first have to figure out how to survive the first week, right?
- 1:35SPEAKER_00: Like if you're listening to this on a flight to KL right now, you might be wondering, or honestly panicking, about what happens the day after the injection.
- 1:43SPEAKER_02: Aaron Powell Oh, absolutely.
- 1:44SPEAKER_02: The anxiety is real.
- 1:46SPEAKER_02: But that immediate post-injection window, it's really just a phase of cellular signaling.
- 1:52SPEAKER_02: It requires a lot of patience.
- 1:54SPEAKER_00: Aaron Powell So what's actually happening?
- 1:56SPEAKER_00: Does the pain just vanish?
- 1:57SPEAKER_02: Aaron Powell No, no.
- 1:58SPEAKER_02: Early pain relief is definitely not immediate.
- 2:01SPEAKER_02: Most patients go back to light daily activity in a day or two, but you will likely actually experience some mild swelling or stiffness, maybe even some soreness at the injection site.
- 2:11SPEAKER_00: Aaron Powell See, that's exactly when a patient thinks, I spent all this time and money, and my knee actually feels worse.
- 2:16SPEAKER_00: This whole thing failed.
- 2:17SPEAKER_02: Aaron Powell Which is the most common fear.
- 2:19SPEAKER_02: But biologically, it's the exact opposite of a failure.
- 2:23SPEAKER_02: The injected cells, uh, they're acting like site managers.
- 2:26SPEAKER_00: Aaron Powell Okay, site managers.
- 2:28SPEAKER_00: Yeah.
- 2:28SPEAKER_00: I like that.
- 2:28SPEAKER_02: Trevor Burrus, Jr.: Yeah, they're releasing this whole cascade of growth factors and anti-inflammatory signals.
- 2:33SPEAKER_02: Think of them as, well, like chemical text messages that need time to alter the joint's environment.
- 2:39SPEAKER_02: So the swelling is just a sign of your joint actively responding to those signals.
- 2:44SPEAKER_00: Aaron Powell It's basically the cells building the biological scaffolding for the next 12 months.
- 2:48SPEAKER_00: So it's kind of like planting a seed in your garden, right?
- 2:51SPEAKER_00: You don't dig it up three days later to see if it's growing.
- 2:53SPEAKER_02: Aaron Powell That is a perfect analogy.
- 2:54SPEAKER_02: Yes.
- 2:55SPEAKER_02: Trevor Burrus, Jr.
- 2:55SPEAKER_00: Yeah, because all that crucial initial work is happening completely out of sight, beneath the soil, establishing the root system.
- 3:02SPEAKER_00: It's just human nature to crave instant gratification.
- 3:05SPEAKER_00: We're so used to uh swallowing an ibuprofen and feeling a headache vanish in 20 minutes.
- 3:09SPEAKER_02: Aaron Powell We really do expect biology to operate on a digital timetable, but biology absolutely refuses to be rushed.
- 3:17SPEAKER_02: Right.
- 3:17SPEAKER_02: The cellular mechanisms, like how your immune system's macrophages shift from being pro-inflammatory to anti-inflammatory, that takes weeks to fully activate.
- 3:28SPEAKER_00: So icing the joint and limiting high-impact stuff is smart, but it doesn't magically speed up the biology.
- 3:34SPEAKER_02: Aaron Powell Exactly.
- 3:36SPEAKER_02: Judging the results in week one just sets a completely unrealistic bar.
- 3:40SPEAKER_02: Most of these published trials don't even bother measuring for meaningful change until the one-month mark at the absolute earliest.
- 3:47SPEAKER_00: Aaron Powell Okay, so if the first month is just the site managers setting up the scaffolding, when do we actually see the building go up?
- 3:54SPEAKER_00: The sources talk about a massive review of randomized trials using uh sucre scores.
- 3:59SPEAKER_02: Yes, sucre scores.
- 4:00SPEAKER_02: For anyone not reading medical journals for fun, higher scores basically mean a specific treatment consistently outperformed others on average across these trials.
- 4:10SPEAKER_00: Got it.
- 4:11SPEAKER_00: So what shifts when we hit that first real checkpoint at three months?
- 4:15SPEAKER_02: At three months, the early pain relief becomes consistently measurable.
- 4:19SPEAKER_02: The data shows that high dose autologous cells, meaning stem cells from the patient's own body, like from bone marrow or fat, ranked highest for early pain relief across all the checkpoints.
- 4:30SPEAKER_00: So they have an immediate cytokine profile that's really good at turning down the initial pain response.
- 4:34SPEAKER_00: But what about the six-month mark?
- 4:36SPEAKER_02: Aaron Powell That's where the landscape really shifts.
- 4:38SPEAKER_02: Function scores start catching up to the pain improvements.
- 4:42SPEAKER_02: The trials showed that high-dose donor-derived cells actually ranked best for improving actual joint function at six and twelve months.
- 4:50SPEAKER_00: Oh wow.
- 4:51SPEAKER_00: And there was that fascinating separate trial in the sources, the one looking at early stage knee osteoarthritis.
- 4:57SPEAKER_02: Right.
- 4:58SPEAKER_02: The one comparing adipose-derived cells, so from fat tissue, directly against standard hyaluronic acid injections.
- 5:04SPEAKER_00: Yeah.
- 5:05SPEAKER_00: And the cell group obviously showed better pain and stiffness scores, but the detail that stopped me in my tracks was the imaging.
- 5:11SPEAKER_00: The MRI scans literally showed less cartilage loss in the cell group.
- 5:16SPEAKER_02: Aaron Powell That cartilage finding is huge because it highlights a fundamental disconnect in how we normally understand joint health.
- 5:23SPEAKER_02: We are so conditioned by traditional medicine to think that a damaged physical structure equals pain, and a repaired structure equals relief.
- 5:31SPEAKER_00: Wait, hold on.
- 5:32SPEAKER_00: Are you saying I could look at an x-ray of a completely shredded bone-on-bone knee, but the patient might be out walking a golf course with zero pain?
- 5:41SPEAKER_00: Or the other way around, I could have a structurally beautiful knee on an MRI that hurts constantly?
- 5:46SPEAKER_02: Yes, exactly.
- 5:48SPEAKER_02: And the reason for that is how pain actually works in the joint.
- 5:52SPEAKER_02: Cartilage itself is completely a neural.
- 5:55SPEAKER_00: Meaning it doesn't have nerves.
- 5:56SPEAKER_02: Exactly.
- 5:57SPEAKER_02: It doesn't have nosoceptors, which are those specialized nerve endings that detect damage and tell your brain you're in pain.
- 6:03SPEAKER_02: You could theoretically drill a hole straight into healthy cartilage and feel absolutely nothing.
- 6:08SPEAKER_00: Aaron Powell That is wild.
- 6:10SPEAKER_00: So where is the pain even coming from then?
- 6:12SPEAKER_02: Aaron Powell The pain in osteoarthritis mostly comes from the chronic inflammation of the joint lining, the synovium.
- 6:19SPEAKER_02: Or it comes from the underlying bone when the cartilage wears away completely and exposes that nerve-rich tissue underneath.
- 6:25SPEAKER_00: Aaron Powell So the stem cells aren't necessarily regrowing a massive brand new shock absorber of cartilage in six months.
- 6:31SPEAKER_00: Like they aren't rebuilding the tire.
- 6:34SPEAKER_02: Aaron Ross Powell In most cases, no, they aren't.
- 6:36SPEAKER_02: What the stem cells are doing is acting as incredibly potent anti-inflammatory agents.
- 6:41SPEAKER_02: They calm that angry inflamed synovium.
- 6:44SPEAKER_00: Aaron Powell So they literally change the biochemical makeup of the fluid inside the knee.
- 6:48SPEAKER_02: Aaron Powell Precisely.
- 6:49SPEAKER_02: The pain drops, function improves.
- 6:52SPEAKER_02: Even if the cartilage hasn't fully regenerated on a follow-up x-ray, they are basically turning off the blaring fire alarm in the house, even if the house itself hasn't been completely rebuilt.
- 7:04SPEAKER_00: Man, if the nervous system's perception of pain is that malleable, and just turning off the chemical fire alarm makes people feel that much better, it makes me wonder how much of this relief is strictly biological and how much is psychological.
- 7:17SPEAKER_02: Aaron Powell Which brings us to the biggest elephant in the room.
- 7:19SPEAKER_00: Aaron Powell Yeah.
- 7:20SPEAKER_00: Because the sources included a separate systematic review focusing on contextual effects in these clinical trials.
- 7:27SPEAKER_00: And this feels like the massive caveat that those glossy clinic brochures conveniently leave out.
- 7:32SPEAKER_02: Aaron Powell It's a substantial, undeniable factor.
- 7:35SPEAKER_02: This review estimated that contextual factors account for roughly half to two-thirds of the total improvement seen by patients in stem cell trials for knee osteoarthritis.
- 7:45SPEAKER_02: Two-thirds.
- 7:47SPEAKER_00: Okay.
- 7:47SPEAKER_00: To be absolutely clear here, contextual effects is just a polite scientific term for the placebo response, right?
- 7:54SPEAKER_00: Like the patient's own expectations of healing and the psychological impact of having doctors pay really close attention to you.
- 8:00SPEAKER_02: Aaron Powell That's exactly what it is.
- 8:02SPEAKER_02: The researchers found that the physical stem cells themselves add a real but modest biological benefit on top of that massive contextual healing.
- 8:11SPEAKER_00: I mean, half to two-thirds is a lot.
- 8:13SPEAKER_02: It is.
- 8:14SPEAKER_02: The review authors do note the certainty of these specific percentage estimates is low.
- 8:20SPEAKER_02: Simply because separating the mind from the body in a clinical trial is incredibly difficult, but the underlying mechanism is absolutely real.
- 8:28SPEAKER_00: Aaron Powell Right, because the mind-body connection heavily influences inflammatory pathways.
- 8:33SPEAKER_02: Exactly.
- 8:34SPEAKER_02: And how the brain processes pain signals.
- 8:37SPEAKER_02: The whole ritual of traveling to a clinic in KL, the anticipation of a cutting-edge procedure, the ongoing care, all of this signals the brain's descending pain modulatory system to release endogenous opioids.
- 8:50SPEAKER_02: It literally lowers your internal pain dial.
- 8:52SPEAKER_00: Aaron Powell I just really don't want a listener hearing that and feeling cheated, you know, like they're thinking the therapy is somehow a scam.
- 8:58SPEAKER_00: It's really like hitting a golf ball with a brand new, highly engineered titanium driver.
- 9:04SPEAKER_02: Oh, that's a great way to look at it.
- 9:05SPEAKER_00: Yeah, because some of the extra distance is absolutely the titanium technology in the clubhead, but a huge portion of it is just you swinging more confidently with better mechanics because you firmly believe in the club.
- 9:16SPEAKER_02: Absolutely.
- 9:17SPEAKER_02: A 50 or 60% contextual effect doesn't mean the cells are doing nothing.
- 9:22SPEAKER_02: It means our own brains are doing a massive amount of the heavy lifting.
- 9:26SPEAKER_02: We shouldn't be discouraged by that.
- 9:28SPEAKER_02: We should really respect how powerful our expectations are.
- 9:31SPEAKER_00: So if my mind is already driving over half the healing, how much does the physical origin of the stem cell even matter?
- 9:38SPEAKER_00: Like if I use my own aging cells for my bone marrow versus younger donor cells, does the biology actually shift the outcome or is it just more placebo?
- 9:47SPEAKER_02: Aaron Powell Oh, the biology shifts dramatically.
- 9:50SPEAKER_02: The goal of clinical science isn't to eliminate the contextual effect, but to harness it and then maximize the specific biological benefit the cells add on top.
- 10:00SPEAKER_02: To do that, you have to optimize two critical variables, the source of the cells and the dosage.
- 10:06SPEAKER_00: Okay, so the sources mention bone marrow and adipose tissue are the most heavily studied historically, but there's a major shift happening in the industry now.
- 10:15SPEAKER_02: Aaron Powell There is.
- 10:26SPEAKER_00: Why the shift to umbilical cord cells, though?
- 10:28SPEAKER_00: What's the biological mechanism there?
- 10:30SPEAKER_02: Aaron Powell It really comes down to cellular exhaustion and a concept called immune privilege.
- 10:36SPEAKER_02: When you use an older patient's autologous cells, meaning we harvest your own bone marrow or fat to reinject into your knee, you are using cells that have aged right alongside you.
- 10:45SPEAKER_00: Aaron Powell So they're tired.
- 10:47SPEAKER_02: Aaron Powell Exactly.
- 10:48SPEAKER_02: Their telomeres, those protective caps on the ends of their DNA, are shorter.
- 10:52SPEAKER_02: They've been exposed to decades of systemic inflammation, environmental stress, poor diet.
- 10:58SPEAKER_00: Aaron Ross Powell I've heard some of them even become senescent, like they're basically zombie cells that stop dividing and actually secrete inflammatory chemicals.
- 11:05SPEAKER_02: Aaron Powell Yes.
- 11:06SPEAKER_02: They have a naturally diminished regenerative capacity.
- 11:10SPEAKER_02: WJMSCs, on the other hand, are essentially day zero cells.
- 11:14SPEAKER_00: Aaron Ross Powell They haven't lived a hard life yet.
- 11:16SPEAKER_02: Aaron Powell Right.
- 11:16SPEAKER_02: Wharton's jelly is the gelatinous substance inside the umbilical cord.
- 11:21SPEAKER_02: The cells harvested from this tissue are incredibly robust.
- 11:25SPEAKER_02: They multiply faster, they secrete higher levels of growth factors.
- 11:28SPEAKER_00: Aaron Powell And what about that immune privilege thing you mentioned?
- 11:31SPEAKER_02: Aaron Ross Powell Crucially, they lack certain markers on their surface that would normally trigger an immune response.
- 11:37SPEAKER_02: This means they generally trigger a significantly weaker immune reaction from the patient's body compared to transplanting adult cells from a donor.
- 11:44SPEAKER_00: Aaron Powell So it's kind of like using fresh, nutrient-rich potting soil for a garden.
- 11:49SPEAKER_00: Your own 60-year-old bone marrow cells are like soil that's been farmed aggressively for decades.
- 11:53SPEAKER_00: It's depleted, the nutrients are completely exhausted.
- 11:57SPEAKER_01: Aaron Powell I love that.
- 11:58SPEAKER_00: Yeah.
- 11:59SPEAKER_00: Wharton's jelly cells haven't been subjected to that wear and tear, so their biological signaling power is much stronger.
- 12:05SPEAKER_00: You're starting with a fundamentally better foundation.
- 12:08SPEAKER_02: Aaron Powell The biological premise for this shift is incredibly compelling.
- 12:12SPEAKER_02: Rigorous head-to-head trials are still ongoing to definitively prove if this core drive source translates to a noticeably faster timeline across massive populations.
- 12:21SPEAKER_02: But the theoretical advantages are what's driving the industry forward.
- 12:25SPEAKER_00: And alongside the source, the data clearly shows that higher doses yield stronger, more consistent results, right?
- 12:31SPEAKER_00: The more robust cells you introduce as site managers, the better the joint environment can be altered.
- 12:37SPEAKER_02: Exactly.
- 12:37SPEAKER_02: But the sources also highlight something I rarely see in standard bargaining pitches, which is the timing of a second dose.
- 12:44SPEAKER_00: Aaron Powell Yeah.
- 12:45SPEAKER_00: Everyone always focuses on the single magic injection, but the data suggests timing a second infusion at a set interval helps sustain the improvement through the full 12 months.
- 12:55SPEAKER_00: It's almost like a booster shot to remind the immune system to keep the inflammation down.
- 12:59SPEAKER_02: Aaron Powell Because relying entirely on a single intervention ignores the biomechanical reality of chronic joint disease.
- 13:06SPEAKER_02: Even with the perfect dose of high-quality WJMSCs, these cells do not operate in a vacuum.
- 13:13SPEAKER_00: Aaron Powell Right, which brings us to the patient's actual role in all of this.
- 13:16SPEAKER_00: If I fly back home to Australia after my procedure in KL, what is my actual job for the next 12 months?
- 13:22SPEAKER_00: What helps or hurts my progress?
- 13:24SPEAKER_02: Aaron Ross Powell Your primary job is managing the physical environment of the joint.
- 13:28SPEAKER_02: Carrying extra body weight can severely offset the benefits of cell therapy.
- 13:33SPEAKER_02: There's a brutal multiplier effect in joint mechanics.
- 13:36SPEAKER_00: Oh, the force multiplier.
- 13:38SPEAKER_00: For every one kilogram of extra body weight you carry, it translates to roughly four kilograms of excess force on your knee with every single step.
- 13:46SPEAKER_02: Yes.
- 13:47SPEAKER_02: If you mechanically overload the newly treated joint, you are destroying the scaffolding faster than the cells can build it.
- 13:53SPEAKER_00: That math is just wild to think about.
- 13:55SPEAKER_00: Losing just five kilograms removes 20 kilograms of stress from the knee.
- 14:00SPEAKER_02: The structural load matters immensely.
- 14:03SPEAKER_02: Similarly, systemic issues like smoking and poorly controlled diabetes actively sabotage the healing process.
- 14:10SPEAKER_00: Aaron Powell Because they mess with blood flow.
- 14:12SPEAKER_02: Exactly.
- 14:13SPEAKER_02: They cause systemic vasoconstriction, meaning poor blood flow, and they maintained a state of chronic inflammation in the body.
- 14:19SPEAKER_02: They actively fight against the anti-inflammatory signals the stem cells are trying to establish.
- 14:24SPEAKER_00: And what about rehab?
- 14:26SPEAKER_02: Physical therapy and movement are mandatory standard care.
- 14:30SPEAKER_02: Cartilage and joints receive their nutrition through movement.
- 14:33SPEAKER_02: The pumping action of walking circulates the synovial fluid which feeds the tissue.
- 14:38SPEAKER_00: So sitting on the couch for a year to protect your investment is literally the worst thing you can do.
- 14:44SPEAKER_00: Rehab and movement aren't optional add-ons for when you have free time on a Tuesday.
- 14:48SPEAKER_02: Not at all.
- 14:49SPEAKER_02: They are essential.
- 14:51SPEAKER_00: So who tends to see the clearest benefit when they do all this right?
- 14:55SPEAKER_02: Aaron Ross Powell A clear pattern really emerges in the clinical data.
- 14:58SPEAKER_02: Patients presenting with milder, early stage knee changes respond much more predictably than those with advanced bone-on-bone joint damage.
- 15:06SPEAKER_00: Makes sense.
- 15:07SPEAKER_00: If the physical architecture of the joint is severely compromised or the joint space is completely gone, the cells just have very little room or remaining tissue to work with.
- 15:16SPEAKER_02: Right.
- 15:17SPEAKER_02: Additionally, a prior positive response to treatments like platelet-rich plasma, so PRP, or hyaluronic acid injections, is an excellent prognostic indicator.
- 15:28SPEAKER_00: It basically proves the joint's environment is still responsive to biological or lubricating interventions.
- 15:34SPEAKER_00: It's a strong clue that the biological pathways are still open for business.
- 15:38SPEAKER_02: Exactly.
- 15:39SPEAKER_02: And then there's the whole issue of tracking this progress at home.
- 15:42SPEAKER_00: Yeah, because waiting quietly for a year just hoping to magically feel better one morning is a terrible strategy.
- 15:49SPEAKER_00: Now, our sources suggest patients use a simple, consistent pain diary, but I actually have to push back on that based on what we discussed earlier about the placebo effect.
- 15:57SPEAKER_02: Aaron Powell Oh, I see where you're going with this.
- 16:00SPEAKER_00: If you are constantly tracking your pain every single day, aren't you just hyper-fixating on it?
- 16:05SPEAKER_00: If the mind-body connection is really as powerful as we established, staring at your knee and asking, does it hurt every morning seems like a recipe for making it feel worse.
- 16:15SPEAKER_00: The brain pays attention to what we focus on.
- 16:17SPEAKER_02: Aaron Powell That is a highly valid concern.
- 16:20SPEAKER_02: And it taps right into the neuroplasticity of pain.
- 16:23SPEAKER_02: Tracking purely subjective pain can easily lead to hyperfixation.
- 16:28SPEAKER_02: Your brain actually becomes more efficient at feeling the pain because you are constantly training it to look for it.
- 16:34SPEAKER_00: Right.
- 16:34SPEAKER_00: So what's the alternative?
- 16:36SPEAKER_02: This is why the guidelines strongly recommend tracking a specific physical function instead of a subjective feeling.
- 16:43SPEAKER_00: What does that actually look like in practice for a patient at home?
- 16:46SPEAKER_02: It could be climbing a specific flight of stairs without needing to stop, or timing a comfortable 10-minute walk around your neighborhood.
- 16:53SPEAKER_02: Functional goals mirror how the clinical trials themselves measure progress.
- 16:58SPEAKER_02: It gives you objective, concrete data, like can I walk further today than I could two months ago without needing to sit down.
- 17:05SPEAKER_00: I love that.
- 17:06SPEAKER_00: Functional tracking takes all the emotion out of it.
- 17:09SPEAKER_00: Asking how much does my knee hurt today depends on, you know, your mood, how poorly you slept, or how stressed you are about work.
- 17:16SPEAKER_00: Exactly.
- 17:16SPEAKER_00: Timing a 10-minute walk is objective math.
- 17:19SPEAKER_00: It's a much healthier metric.
- 17:21SPEAKER_00: And the sources note that if a patient's pain worsens significantly beyond the normal soreness of that first week, or if there is absolutely zero functional change by the three-month mark, they really need to reach out to their physician.
- 17:33SPEAKER_02: Right.
- 17:34SPEAKER_02: It isn't about panicking early, but it is about being realistic if the major milestones are completely missed.
- 17:40SPEAKER_02: Functional goals keep you actively engaged in your own recovery, looking forward rather than inward.
- 17:47SPEAKER_00: And that active participation ties directly back into maximizing those powerful contextual benefits we discussed earlier.
- 17:54SPEAKER_00: You are actively participating in your own healing ritual.
- 17:58SPEAKER_02: Exactly.
- 17:59SPEAKER_02: You're giving your brain the signals it needs to aid the recovery.
- 18:03SPEAKER_00: So as we wrap up this deep dive, the main takeaway for you listening right now is that there is no single success rate, and absolutely no magic wand for knee pain.
- 18:13SPEAKER_00: Recovery following a stem cell injection is a gradual biological build that takes place over three to twelve months.
- 18:20SPEAKER_02: It really does.
- 18:21SPEAKER_00: It requires profound patience, realistic expectations regarding how much of the healing comes from your own mind-body connection versus the physical cells themselves, and your active participation through rehab, weight management, and functional tracking.
- 18:36SPEAKER_02: And you know, we learned today that simply receiving attention, undergoing a ritual of care, and having expectations during a medical procedure can account for up to two-thirds of your knees improvement.
- 18:47SPEAKER_02: It really makes you wonder if the context of healing is that powerful, how might bringing that same level of intentional, focused belief to our everyday physical therapy, our diet, or our daily walks change our baseline health even before we step foot in a clinic?
- 19:03SPEAKER_00: Wow.
- 19:04SPEAKER_00: I will definitely be thinking about that the next time I step into a gym or head out for a walk.
- 19:09SPEAKER_00: Your mindset and your environment are just as crucial as the cellular science.
- 19:14SPEAKER_00: Take this grounded, evidence-based perspective and apply it to your own health journey wherever it takes you.
- 19:19SPEAKER_00: Keep moving, stay curious, and we will catch you on the next deep dive.